Gln-Atovaquone 750 mg (Atovaquone SUSPENSION) 750 MG

Atovaquone 750 mg suspension is an oral medication used to treat certain infections. This broad-spectrum antiparasitic is commonly prescribed for conditions like malaria and pneumonia.

Strength

750 MG

Manufacturer / TM Owner

GLENMARK PHARMACEUTICALS CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Atovaquone 750 mg suspension is primarily used to treat parasitic infections, including malaria and pneumonia caused by Pneumocystis jirovecii. It is often prescribed for individuals who cannot tolerate or do not respond to other treatments. The medication works by interfering with the parasite's ability to reproduce, helping to clear the infection.

Side Effects

Common effects of Atovaquone 750 mg suspension may include nausea, vomiting, diarrhea, and stomach pain. Some users might experience headache, dizziness, or rash. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare provider.

Precautions & Warnings

Atovaquone 750 mg suspension should be used with caution in individuals with liver or kidney problems. It is important to follow the prescribed dosage and complete the full course of treatment. Avoid taking this medication with high-fat meals, as it can reduce its effectiveness. Always store the suspension properly and keep it out of reach of children.

Avoid Interactions

Atovaquone 750 mg suspension may interact with certain medications, including antacids, metoclopramide, and drugs that induce liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be limited, as it may exacerbate side effects.

Frequently Asked Questions

Atovaquone 750 mg suspension is used to treat parasitic infections, including malaria and pneumonia caused by Pneumocystis jirovecii.

Atovaquone 750 mg suspension is typically taken orally, with water, and should be shaken well before use. It is best taken with food to enhance absorption.

Common side effects may include nausea, vomiting, diarrhea, stomach pain, headache, dizziness, and rash.

Atovaquone 750 mg suspension may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

The safety of Atovaquone 750 mg suspension in children should be discussed with a healthcare provider, as it depends on the specific condition and individual health factors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.